Adrenocortical carcinoma (ACC) is a rare type of cancer that is associated with a high rate of recurrence and poor prognosis. The main diagnostic approaches to adrenocortical cancer include CT scan, MRI and the promising role of F-FDG PET/CT. The main therapeutic approaches include radical surgery of local disease and recurrences, as well as adjuvant mitotane therapy. The evaluation of adrenocortical carcinoma (ACC) could be difficult by using F-FDG PET/CT in view of the significant association between the F-FDG uptake and ACC. At the same time, not all adrenal glands with F-FDG uptake are considered to be malignant, so awareness of these various findings is substantial for ACC management, especially with limited data regarding the role of F-FDG PET/CT in ACC post-operative settings. This report discusses the case of a 47-year-old man with a history of left adrenocortical carcinoma who underwent adrenalectomy and received adjuvant mitotane therapy. 9 months after the surgery, a follow-up F-FDG PET/CT scan showed that the F-FDG uptake was prominent in the right adrenal gland without corresponding abnormal CT scan findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261690PMC
http://dx.doi.org/10.22038/AOJNMB.2022.67950.1472DOI Listing

Publication Analysis

Top Keywords

f-fdg uptake
16
f-fdg pet/ct
16
adrenocortical carcinoma
12
adrenal gland
8
carcinoma acc
8
role f-fdg
8
adjuvant mitotane
8
mitotane therapy
8
f-fdg
7
adrenocortical
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!